1) Double route arterial chemotherapy
双路动脉化疗
2) two route-chemotherapy
双路化疗
1.
Evaluation of two route-chemotherapy for advanced gastric cancer ascites;
进展期胃癌合并恶性腹水术前双路化疗的应用价值
2.
Objective: To evaluate the effects of two route-chemotherapy for the patients with advanced gastric cancer asdtes.
目的:探讨进展期胃癌合并恶性腹水术前双路化疗的效果。
3) two route chemotherapy
双路化疗
1.
Objective To value the therapeutic effect and toxicity of two route chemotherapy and intravenous chemotherapy in advanced gastric and colorectal cancer.
目的 评价双路化疗与静脉化疗治疗晚期胃肠肿瘤的疗效及毒副反应。
4) intra-arterial chemotherapy
动脉化疗
1.
The outcome of bladder-sparing surgery combined with intra-arterial chemotherapy for invasive bladder cancer;
保留膀胱手术联合动脉化疗治疗浸润性膀胱癌的临床研究
2.
Method: 156 cancer patients with an indication of intra-arterial chemotherapy were randomly divided into two groups, 78 cases each receiving cisplatin (≥50mg/m2) and doxorubicin (≥40 mg/m2) respectively in the therapy scheme.
入选病例为具备介入动脉化疗或(和)栓塞治疗适应证且化疗方案中均含有顺铂≥50mg/m~2或(和)阿霉素≥40mg/m~2(吡喃阿霉素≥40mg/m~2,表阿霉素≥80mg/m~2)化疗药物。
3.
Several studies indicates that gemcitabine based intra-arterial chemotherapy may be effective in treating advanced pancreatic cancer.
动脉化疗可以通过对肿瘤动脉的局部灌注使肿瘤组织有较高的药物分布,有研究表明吉西他滨联合药物动脉化疗可能对晚期胰腺癌有效。
5) Arterial chemotherapy
动脉化疗
1.
To investigate the influence of preoperative arterial chemotherapy on the expression of p53 and proliferating cell nuclear antigen (PCNA) in bladder cancer.
[目的]探讨术前动脉化疗对膀胱癌p53和增殖细胞核抗原(PCNA)表达的影响及临床意义。
6) Chemotherapy
[英][,ki:məʊ'θerəpi] [美]['kimo'θɛrəpɪ]
动脉化疗
1.
To investigate the effect of systematic chemotherapy combined with Aidi injection transhepatic arterial infusion in treatment for liver cancer.
其中,A组51例周围静脉化疗,B组51例肝动脉化疗,C组52例化疗联合艾迪注射液肝动脉灌注。
补充资料：动脉-动脉分流型双胎阻断序列征
动脉-动脉分流型双胎阻断序列征
在早期如果双胎中一个胎儿的动脉压大于另一个，动脉压低者接受另一胎儿的血。用过的动脉血又注入髂血管，故注入下身的血多于上身。结果造成许多已形成和正在形成的组织发育阻断，退化而致形态发生不全成为畸形。常失去的组织有头部、心脏、上肢、肺脏、胰脏、上部肠。阻断破坏重者只留下一些残余组织，如无定形双胎，有轻有重，几乎无一例相同。供血的胎儿心脏大，代偿失调，继发肝功能异常，低血色素贫血，水肿，有时如水泡样。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条